Neuropace Inc (NPCE) Live Share Price, Invest From India

Neuropace Inc Stock Performance

as on March 4, 2026 at 6:12 am IST

Day's Low
Day's High
$13.30
Day's Price Range
$14.05
$13.94
4.59%
Downside
0.79%
Upside
52 Week's Low
52 Week's High
$7.56
52-Week Price Range
$18.98
$13.94
45.75%
Downside
36.12%
Upside

Neuropace Inc share price movements today

Previous Close: $14.15
Open: $13.52
Volume: 200.8K
Day's Low - High: $13.30 - $14.05
52 Week Low - High: $7.56 - $18.98

Neuropace Inc Historical Returns

1 Month Return: -12.55 %
3 Month Return: -15.07 %
1 Year Return: + 19.81 %
3 Year Return: + 245.12 %
5 Year Return: 0 %

Neuropace Inc Stock Fundamentals & Key Indicators

Check Neuropace Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$485.6M

EPS (TTM)

-0.7674

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-7.76

Industry PE ratio

-3.105112781954887

PEG Ratio

EBITDA

-18.0M

Revenue (TTM)

94.9M

Profit Margin

-25.29%

Return On Equity TTM

-169.27%

Neuropace Inc Stock Valuation

Track how Neuropace Inc P/E has moved over time to understand its valuation trends.

Neuropace Inc in the last 5 years

Overview
Trends

Lowest (-23.06x)

December 31, 2025

Today (-7.76x)

March 3, 2026

Industry (-3.11x)

March 3, 2026

Highest (-0.38x)

December 31, 2021

LowHigh

Today’s Price to Earnings Ratio: -7.76x

Neuropace Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Neuropace Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Neuropace Inc	BUY	$485.6M	NA	-7.76	-25.29%
Boston Scientific Corp.	BUY	$114.0B	96.34%	39.61	14.44%
Stryker Corporation	BUY	$148.3B	59.35%	46.07	12.92%
Medtronic Plc	BUY	$125.4B	-16.83%	27.28	13.00%
Abbott Laboratories	BUY	$202.5B	-4.25%	31.28	14.72%

See all

Stock Returns calculator for Neuropace Inc Stock including INR - Dollar returns

The Neuropace Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Neuropace Inc investment value today

Current value as on today

₹1,23,540

Returns

₹23,540

(+23.54%)

Returns from Neuropace Inc Stock

₹18,036 (+18.04%)

Dollar Returns*

₹5,505 (+5.5%)

Analyst Recommendation on Neuropace Inc Stock

Based on 13 analysts

BUY

84.62%

Buy

15.38%

Hold

0.00%

Sell

Based on 13 analysts, 84.62% of analysts recommend a 'BUY' rating for Neuropace Inc. Average target price of $19.5

Neuropace Inc Share Price Target

Get share price movements and forecasts by analysts on Neuropace Inc.

What analysts predicted

28.51%UPSIDE

Target Price

$19.5

Current Price

$13.94

Analyzed by

13 Analysts

Target

$19.50

Neuropace Inc target price $19.5, a slight upside of 28.51% compared to current price of $13.94. According to 13 analysts rating.

Neuropace Inc Stock’s Investor Sentiment and Interest

Search interest for Neuropace Inc Stock has decreased by -48% in the last 30 days, reflecting a downward trend in search activity.

Time period: February 2, 2026 to March 4, 2026

Change:-48% versus previous 30 day period

Neuropace Inc Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Total Revenue	16	16	18	18	19	21	21	22	23	27
Gross Profit	11	12	13	13	14	15	16	17	18	21
Operating Income	-7	-5	-5	-7	-6	-4	-3	-5	-6	-2
EBITDA	-6	-4	-3	-6	-4	-2	-2	-3	-6	-2
Interest Expense	2	2	2	2	2	2	2	2	2	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-9	-7	-6	-8	-7	-5	-5	-6	-8	-3
Income Tax Expense	2	2	-8	0	-	-	0	-	-	-
Net Income	-9	-7	-6	-8	-7	-5	-5	-6	-8	-3
Net Profit Margin	-55.26%	-44.18%	-34.42%	-49.24%	-39.02%	-25.89%	-24.46%	-29.25%	-36.78%	-12.78%

Neuropace Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	36	41	45	45	65	79
Gross Profit	26	30	33	32	48	59
Operating Income	-22	-13	-23	-40	-27	-21
EBITDA	-20	-12	-28	-36	-22	-16
Interest Expense	9	11	7	7	8	8
Depreciation	0	0	0	2	1	1
Income Before Tax	-29	-24	-36	-47	-32	-27
Income Tax Expense	10	11	2	6	1	-
Net Income	-29	-24	-36	-47	-32	-27
Net Profit Margin	-81.07%	-59.02%	-79.85%	-103.43%	-50.38%	-33.97%

Neuropace Inc Quarterly Cash Flow

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Net Income	-7	-6	-8	-7	-5	-5	-6	-8	-3
Operating Cash Flow	-2	-3	-7	-3	-1	-4	-7	-2	-1
Investing Cash Flow	4	3	2	3	1	1	0	0	0
Financing Cash Flow	0	8	0	0	2	0	21	-1	0
Change in Cash	1	8	-5	0	2	-1	13	-4	-2

Neuropace Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-24	-36	-47	-32	-27
Operating Cash Flow	-21	-24	-36	-19	-17
Investing Cash Flow	-10	-85	23	23	8
Financing Cash Flow	55	102	0	8	4
Change in Cash	22	-7	-12	11	-4

Global Institutional Holdings in Neuropace Inc

Funds	Holdings
State Street Corp	1.11%
Geode Capital Management, LLC	1.68%
Renaissance Technologies Corp	0.67%
Silvercrest Asset Management Group LLC	0.9%
Orbimed Advisors, LLC	7.9%

See all

Insights on Neuropace Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -8.65M → -3.49M (in $), with an average increase of 147.5% per quarter
POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 9 quarters, 16.42M → 27.35M (in $), with an average increase of 6.1% per quarter
POSITIVE IMPACT
Best in 3 Years
In the last 3 years, NPCE has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Price Rise
In the last 3 years, NPCE stock has moved up by 245.1%
NO EFFECT
Against Peers
In the last 1 year, Edwards Lifesciences Corp. has given 22.1% return, outperforming this stock by 2.3%

About Neuropace Inc

the rns® system is an award-winning technology developed and manufactured in silicon valley that has been recognized for its innovation. similar to a pacemaker that monitors and responds to heart rhythms, the rns system is the world's first and only medical device that can monitor and respond to brain activity. neuropace was founded to design, develop, manufacture and market implantable devices for the treatment of neurological disorders with responsive stimulation. the company's initial focus is the treatment of epilepsy, a debilitating neurological disorder affecting approximately 1% of the population worldwide.in addition to treating epilepsy, responsive neurostimulation holds the promise of treating several other disabling medical disorders that impact the quality of life for millions of patients around the world.

Organisation	Neuropace Inc
Headquarters	455 North Bernardo Avenue, Mountain View, CA, United States, 94043
Industry	Healthcare
CEO	Mr. Joel D. Becker
E-voting on shares	Click here to vote

Key Management of Neuropace Inc

Name	Title
Dr. Martha J. Morrell M.D.	Chief Medical Officer
Ms. Rebecca L. Kuhn	Advisor
Mr. Dylan St. John	Chief of Operations & Development
Ms. Katie Keller	Vice President of Marketing
Mr. Joel D. Becker	CEO, President & Director
Mr. Patrick F. Williams	Chief Financial Officer
Mr. Scott R. Schaper	Head of Investor Relations
Ms. Leah Akin	General Counsel & Corporate Secretary
Mr. Chris Reese	Senior Vice President of Sales
Ms. Amy Treadwell	Vice President of Human Resources

FAQs

What is Neuropace Inc share price today?

Neuropace Inc share price today is $13.94 as on March 4, 2026 at 12:42 am IST. Neuropace Inc share today touched a day high of $14.05 and a low of $13.3.

What is the 52 week high and 52 week low for Neuropace Inc share?

Neuropace Inc share touched a 52 week high of $18.98 on May 21, 2025 and a 52 week low of $7.56 on August 13, 2025. Neuropace Inc stock price today i.e. March 4, 2026 at 12:42 am IST is trending at $13.94,which is 26.53% down from its 52 week high and 84.33% up from its 52 week low.

What is Neuropace Inc's market capitalisation today?

Neuropace Inc market capitalisation is $0.00T as on March 4, 2026 at 12:42 am IST.

How to invest in Neuropace Inc Stock (NPCE) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Neuropace Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Neuropace Inc Shares that will get you 0.1076 shares as per Neuropace Inc share price of $13.94 per share as on March 4, 2026 at 12:42 am IST.

What is the minimum amount required to buy Neuropace Inc Stock (NPCE) from India?

Indian investors can start investing in Neuropace Inc (NPCE) shares with as little as ₹92.074 or $1 (as of March 4, 2026 at 12:43 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹920.74 in Neuropace Inc stock (as per the Rupee-Dollar exchange rate as on March 4, 2026 at 12:43 am IST). Based on Neuropace Inc share’s latest price of $13.94 as on March 4, 2026 at 12:42 am IST, you will get 0.7174 shares of Neuropace Inc. Learn more about fractional shares .